Dr Andrew Burke

Dr Andrew Burke is dual specialist in both infectious diseases and thoracic medicine. They have diverse clinical experience in low income countries and regional Australia.

Dr Burke is a principal investigator on a number of industry lead trials for pulmonary NTM infection. They are an associate investigator on the FORMAT study assessing clinical outcomes in pulmonary Mycobacterium abscessus infection. Dr Burke is also on the Australian Therapeutic Guidelines writing groups for both antibiotics and respiratory disease.

Dr Burke is the current chair of the steering committee of the Australasian Clinical Tuberculosis network (ACTnet) and is on the Queensland Tuberculosis Expert Advisory Group. They are currently undertaking a PhD in the pharmacokinetics of mycobacterial drugs in people with tuberculosis and cystic fibrosis. As part of their PhD they are exploring the role of therapeutic drug montioring in complex mycobacterial infections.